Filing Details
- Accession Number:
- 0001209191-20-020665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-23 16:47:36
- Reporting Period:
- 2020-03-19
- Accepted Time:
- 2020-03-23 16:47:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1792296 | Jonathan Edwin Tucker | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-19 | 2,000 | $9.91 | 3,500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-03-20 | 2,500 | $11.90 | 6,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $11.896, and the range of prices were between $11.88 and $11.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.